Molecule Details
InChIKeyGTVPOLSIJWJJNY-UHFFFAOYSA-N
Compound NameOlomoucine
Canonical SMILESCn1cnc2c(NCc3ccccc3)nc(NCCO)nc21
Clinical Status Clinical Multi-Target
Targets (Human+Pathogen)2
Pfam Stratification Homologous
Avg pChEMBL8.15
SourceTTD_MultiTarget
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB02116
Drug NameOlomoucine
CAS Number101622-51-9
Groups experimental
ATC Codes nan
Descriptionnan

Categories: Cyclin-Dependent Kinases, antagonists & inhibitors Cytokinins Enzyme Inhibitors Heterocyclic Compounds, Fused-Ring Purines
Cross-references: BindingDB: 5718 ChEBI: 44661 CHEMBL280074 ChemSpider: 4431 PDB: OLO PubChem:4592 PubChem:46508610 Therapeutic Targets Database: DNC001057 Wikipedia: Glial_scar ZINC: ZINC000001641925
Target Activities (2)
Target Gene Organism Category Pfam pChEMBL Type Source
P06493 CDK1 Homo sapiens Human PF00069 8.2 pIC50 TTD_MultiTarget
P24941 CDK2 Homo sapiens Human PF00069 8.2 pIC50 TTD_MultiTarget
DrugBank Target Actions (4)
Target Gene Target Name Action Type
P06493 CDK1 Cyclin-dependent kinase 1 binder targets
P28482 MAPK1 Mitogen-activated protein kinase 1 binder targets
P24941 CDK2 Cyclin-dependent kinase 2 inhibitor targets
Q00535 CDK5 Cyclin-dependent kinase 5 inhibitor targets